Skip to main content
Ind-Swift Laboratories Ltd. logo

Ind-Swift Laboratories Ltd. — Investor Relations & Filings

Ticker · INDSWFTLAB ISIN · INE915B01019 LEI · 335800ZT8UFD9Y8ZMP56 BSE.NS Manufacturing
Open in API
Filings indexed 809 across all filing types
Latest filing 2026-01-14 Investor Presentation
Country IN India
Listing BSE.NS INDSWFTLAB

About Ind-Swift Laboratories Ltd.

https://www.indswiftlabs.com

Ind-Swift Laboratories Ltd. is a global manufacturer specializing in Active Pharmaceutical Ingredients (APIs) and Advanced Intermediates. The company focuses on research and development, process chemistry, and large-scale production across diverse therapeutic segments, including macrolide antibiotics, cardiovascular agents, antihistamines, antidiabetics, and antipsychotics. Operating multiple manufacturing facilities that adhere to international regulatory standards such as USFDA, EDQM, and PMDA, the organization provides high-quality chemical entities to the global market. Its core competencies lie in complex chemical synthesis and the development of cost-effective manufacturing processes for generic and specialty drug substances. The company maintains a strong emphasis on quality assurance and regulatory compliance to support its extensive portfolio of products distributed worldwide.

Recent filings

Filing Released Lang Actions
General Updates
Investor Presentation Classification · 100% confidence The document is titled 'Investor Presentation of Ind-Swift Laboratories Limited' and is addressed to stock exchanges for dissemination to stakeholders, pursuant to SEBI regulations. It contains detailed strategic, operational, and financial information about the company's business transformation, divestment, merger, business units, market presence, and growth plans. The content is typical of an investor presentation, focusing on company strategy, market positioning, and financial highlights rather than a formal financial report or regulatory filing. The document length is substantial (15,000 characters), and it is not a brief announcement or certification. Therefore, the document fits the category of an Investor Presentation (IP).
2026-01-14 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2025. It is a compliance certificate issued by the Registrar and Share Transfer Agent confirming the dematerialization of physical share certificates. The document is short (2927 characters) and primarily serves as a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for compliance certificates and regulatory announcements that do not fit other specific categories.
2026-01-06 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges (BSE and NSE) regarding the closure of the trading window for insiders and designated persons. It references compliance with insider trading regulations and specifies the trading window closure period around the announcement of the company's quarterly financial results for the quarter ended 31st December 2025. The document does not contain any financial data, results, or detailed report content but is an announcement related to trading restrictions ahead of financial results disclosure. It is a regulatory compliance notification rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2025-12-30 English
General Updates
Major Shareholding Notification Classification · 100% confidence The document is a disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. It reports the transmission of shares between promoters due to inheritance, relying on an exemption under Regulation 10(1)(g). The content focuses on share acquisition disclosures and compliance with takeover regulations, specifically reporting to stock exchanges about share transfers within the promoter group. There is no financial data, earnings, management discussion, or report attached. The document is a regulatory disclosure about shareholding changes under takeover regulations, which fits the category of Major Shareholding Notification (MRQ).
2025-12-18 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 100% confidence The document is an official disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. It details the transmission of shares from the legal heirs of a deceased promoter to their joint demat account, with no change in aggregate promoter shareholding. The content focuses on shareholding changes due to transmission and compliance with SEBI takeover regulations. There is no financial report, earnings data, or management discussion. The document is a regulatory disclosure about shareholding changes under takeover regulations, fitting the category of Major Shareholding Notification (MRQ).
2025-12-17 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a short announcement addressed to stock exchanges (BSE and NSE) regarding the receipt of a Good Manufacturing Practice (GMP) certificate from a regulatory body. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 30, which pertains to material event disclosures. The document does not contain financial data, management discussion, or detailed report content. It is a regulatory announcement about a certification event, not a financial report or detailed filing. Given its short length (2024 characters) and nature as a disclosure under SEBI regulations, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-12-15 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.